about
Effects of zolpidem on saccadic eye movements and psychomotor performance: a double-blind, placebo controlled study in healthy volunteers.The effect of repeated doses of temazepam and nitrazepam on human psychomotor performance.Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefitThe clinical use of hypnotics: indications for use and the need for a variety of hypnoticsZaleplon - a review of a novel sedative hypnotic used in the treatment of insomnia.Pharmacokinetics and pharmacodynamics of Ro 41-3696, a novel nonbenzodiazepine hypnotic.Safety of zaleplon in the treatment of insomnia.The use of Valeriana officinalis (Valerian) in improving sleep in patients who are undergoing treatment for cancer: a phase III randomized, placebo-controlled, double-blind study (NCCTG Trial, N01C5).Treatment options for insomnia--pharmacodynamics of zolpidem extended-release to benefit next-day performance.The Importance of Residual Effects When Choosing a Hypnotic: The Unique Profile of ZaleplonInsomnia following traumatic brain injury: a review.The relationship between hippocampal volume and cognition in patients with chronic primary insomnia.Social pharmacology: unresolved critical issues.Is suvorexant a better choice than alternative hypnotics?Treatment of insomnia. Getting to the root of sleeping problems.Association between memory impairment and insomnia among older adults.Possible behavioral consequences of light-induced changes in melatonin availability.Pencil and paper tests--sensitivity to psychotropic drugs.The relationship between serum concentrations and central nervous system actions of metoprolol.Pharmocokinetics and pharmacodynamics of single-dose triazolam: electroencephalography compared with the Digit-Symbol Substitution TestZopiclone produces effects on human performance similar to flurazepam, lormetazepam and triazolam.Efficacy and Safety of the Traditional Herbal Medicine, Gamiguibi-tang, in Patients With Cancer-Related Sleep Disturbance: A Prospective, Randomized, Wait-List-Controlled, Pilot Study.Cognitive and behavioral treatment options for insomnia.Insomnia: I. Classification, assessment and pharmaceutical treatment.Effect of midazolam, flunitrazepam, and placebo against midwinter insomnia in northern Norway.Pharmacokinetics and pharmacodynamics of midazolam after intranasal administration.Effects of removal of phenytoin, carbamazepine, and valproate on cognitive function.A placebo-controlled evaluation of single, escalating doses of CL 284,846, a non-benzodiazepine hypnotic.Benzodiazepines, but not antidepressants or neuroleptics, induce dose-dependent development of tolerance to lorazepam in psychiatric patients.Landmark publications in Psychopharmacology: the first 40 years.Psychological impairment and low-dose benzodiazepine treatment.Cognitive impairment in long-term benzodiazepine users
P2860
Q24538579-583DD050-7B03-4B3A-B0AB-4BE5F3202C79Q24540308-4661B02E-F342-422F-9794-CCF6209FAA35Q26745934-913D652B-C5DC-4CA8-BEE8-5AA67190971DQ29540548-B4921547-9A1A-4C00-976E-14FBCD671841Q31521391-E69C180A-7BFE-4489-90A7-C346FB2BD81AQ34367313-4A00C686-EA27-44BE-9329-80DC00BA8915Q34615602-BD6912F1-1C97-4FC7-B9AF-136BD1E9805AQ34642390-9797995C-FB39-40CF-AC4B-CFBF16ECA5E2Q34840661-A24AF9C5-BEA2-4F78-AECE-8B205E7D65BDQ35665983-55174C5F-A4D8-496D-844F-D0D4753E28ACQ36019499-1DCC9464-B394-44BF-A65E-8BCBE9172B67Q36081778-F09E528B-2504-4533-A2E8-6068DF1F13C9Q40590399-D2253D4D-E587-488C-9B9B-4CD10341E844Q40900071-D9DE2434-BD36-439F-9A3B-0E0F74852267Q41210807-E60503CD-7E55-4E64-B8A3-9C2DAD4B9F20Q41277485-870C8737-DF61-4CC2-B296-27CBB8A3B3D1Q41483782-D9833CD5-20C8-4696-BB02-BD7F68DF80E0Q41868529-034AC2F3-62AA-464F-A870-DCDAE374ADADQ41946119-7BEBFCDF-2323-4ED7-B2C7-552D9F57686CQ42759061-83437D2C-3DCC-4C05-ADEA-0EE7917B9630Q43240439-2BDD661A-40C2-469C-AD79-D00FD34C6F65Q47673326-C6696F00-C7EC-491C-913D-5A5C3ED83784Q48233881-63EB2A53-A4EE-4168-A081-73A96027703CQ49107177-4D19BBC2-283B-4C4A-BD49-685A22A2A17BQ49118954-86D68362-CA36-46F1-9F8A-AF47D83FEDCAQ51537340-317D395E-237C-490A-8D0C-EF2DB4469534Q52056263-236C1DCF-3518-416D-86FB-7D8A80CA5FFCQ52058449-00CFE545-6453-42BE-8301-B9ACD46AEE9AQ52081640-5F80D9F5-78B6-409F-8B50-D42107CCD45CQ53494240-95F1AD2A-E922-4DE8-8F3C-6DEA27F6D370Q55264067-D069F7AC-A600-4876-90A4-C3C62E352DADQ56854518-27811ECB-B7BC-4EE9-AA8D-3331CBF02B4E
P2860
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年学术文章
@wuu
1982年学术文章
@zh
1982年学术文章
@zh-cn
1982年学术文章
@zh-hans
1982年学术文章
@zh-my
1982年学术文章
@zh-sg
1982年學術文章
@yue
1982年學術文章
@zh-hant
name
Sedative-hypnotics and human performance.
@en
Sedative-hypnotics and human performance.
@nl
type
label
Sedative-hypnotics and human performance.
@en
Sedative-hypnotics and human performance.
@nl
prefLabel
Sedative-hypnotics and human performance.
@en
Sedative-hypnotics and human performance.
@nl
P2860
P356
P1433
P1476
Sedative-hypnotics and human performance.
@en
P2093
D A Chernik
L C Johnson
P2860
P2888
P304
P356
10.1007/BF00435262
P577
1982-01-01T00:00:00Z
P6179
1015096653